{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:41:44Z","timestamp":1777480904771,"version":"3.51.4"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"14","license":[{"start":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T00:00:00Z","timestamp":1679011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2021-I2M-1\u2013008"],"award-info":[{"award-number":["2021-I2M-1\u2013008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Understanding the national trends in cardiovascular risk factors control of individuals with prediabetes and diabetes is critical for diabetes prevention and management. Our study aims to estimate how cardiovascular risk factors changed in US adults with different glycemic statuses between 2007\u20132008 and 2017\u20132018.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>This was a serial cross-sectional study based on the National Health and Nutrition Examination Surveys (between 2007\u20132008 and 2017\u20132018 cycle). Non-pregnant American participants aged 20 years or older were included. Cardiovascular risk factors including weight, blood pressure, plasma cholesterol, and smoking by glycemic statuses were estimated. A total of 33 040 American adults were included. From 2007\u20132008 to 2017\u20132018, the age-adjusted proportions of individuals who reached weight control (body mass index &amp;lt;30 kg\/m2) of both normoglycemia group and prediabetes group had a significant decrease over the study period, while the trend in participants with diabetes was not significant (mean difference: -5.34%, 95% confidence interval: -15.28%, 4.59%; P for trend = 0.298). The age-adjusted means of total cholesterol of all three groups decreased during the study decade (P for trend &amp;lt; 0.010), with participants with diabetes maintaining the lowest level. Individuals with high total cholesterol were more likely to receive statin therapy in the diabetes group. Notably, prediabetes participants had the highest level of total cholesterol and low-density lipoprotein cholesterol and were less likely to achieve lipid control with statin therapy. Sensitivity analysis with the second definition of prediabetes and diabetes resulted in a consistent trend.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this nationally representative cross-sectional study, we systematically estimated the cardiovascular risk factors control in American adults and found poor weight control in the normoglycemia and prediabetes group. Despite the significant decrease trend of plasma total cholesterol in all groups, the high cholesterol level in the prediabetes group deserves special concern.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwad080","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T12:56:35Z","timestamp":1679057795000},"page":"1513-1523","source":"Crossref","is-referenced-by-count":5,"title":["Trends in cardiovascular risk factors control among US adults by glycemic statuses, 2007\u20132018"],"prefix":"10.1093","volume":"30","author":[{"given":"Sheng","family":"Yuan","sequence":"first","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxi","family":"Song","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jining","family":"He","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Bian","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihua","family":"Song","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-6338","authenticated-orcid":false,"given":"Kefei","family":"Dou","sequence":"additional","affiliation":[{"name":"Cardiometabolic Medicine Center, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , No. 167, Beilishi Road, Xicheng District, Beijing 100037 , China"},{"name":"State Key Laboratory of Cardiovascular Disease , Shilongxi Road, Mentougou District, Beijing 102308 , China"},{"name":"National Clinical Research Center for Cardiovascular Diseases , Shilongxi Road, Mentougou District, Beijing 102308 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,3,17]]},"reference":[{"key":"2023101001391016100_zwad080-B1","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2023101001391016100_zwad080-B2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the U.S. In 2017","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"2023101001391016100_zwad080-B3"},{"key":"2023101001391016100_zwad080-B4","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","article-title":"American Heart association diabetes committee of the council on lifestyle and cardiometabolic health; council on arteriosclerosis, thrombosis and vascular biology; council on clinical cardiology; and council on hypertension. Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: A scientific statement from the American heart association","volume":"145","author":"Joseph","year":"2022","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B5","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"2023101001391016100_zwad080-B6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2337\/diacare.14.5.366","article-title":"Hypercholesterolemia in diabetes and glucose intolerance in the U. S. Population","volume":"14","author":"Harris","year":"1991","journal-title":"Diabetes Care"},{"key":"2023101001391016100_zwad080-B7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","article-title":"Diabetes, cardiovascular disease and the microcirculation","volume":"17","author":"Strain","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2023101001391016100_zwad080-B8","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"key":"2023101001391016100_zwad080-B9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2022.12567","article-title":"Trends in lipid concentrations and lipid control among US adults, 2007\u20132018","volume":"328","author":"Aggarwal","year":"2022","journal-title":"JAMA"},{"key":"2023101001391016100_zwad080-B10","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/jama.2021.15187","article-title":"Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic Status, 1999\u20132018","volume":"326","author":"He","year":"2021","journal-title":"JAMA"},{"key":"2023101001391016100_zwad080-B11","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/jama.2020.14545","article-title":"Trends in blood pressure control among US adults with hypertension, 1999\u20132000 to 2017\u20132018","volume":"324","author":"Muntner","year":"2020","journal-title":"JAMA"},{"key":"2023101001391016100_zwad080-B12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"2023101001391016100_zwad080-B13"},{"key":"2023101001391016100_zwad080-B14","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1093\/clinchem\/27.12.2008","article-title":"Estimation of very-low-density lipoprotein cholesterol from data on triglyceride concentration in plasma","volume":"27","author":"Wilson","year":"1981","journal-title":"Clin Chem"},{"key":"2023101001391016100_zwad080-B15"},{"key":"2023101001391016100_zwad080-B16","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.2337\/dc21-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021","volume":"44","author":"American Diabetes Association","year":"2021","journal-title":"Diabetes Care"},{"key":"2023101001391016100_zwad080-B17"},{"key":"2023101001391016100_zwad080-B18"},{"key":"2023101001391016100_zwad080-B19","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: A report from the American heart association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B20","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/sim.4780140519","article-title":"Effects of the choice of age-adjustment method on maps of death rates","volume":"14","author":"Pickle","year":"1995","journal-title":"Stat Med"},{"key":"2023101001391016100_zwad080-B21"},{"key":"2023101001391016100_zwad080-B22"},{"key":"2023101001391016100_zwad080-B23","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jama.2020.14590","article-title":"Trends in obesity prevalence by race and hispanic origin-1999\u20132000 to 2017\u20132018","volume":"324","author":"Ogden","year":"2020","journal-title":"JAMA"},{"key":"2023101001391016100_zwad080-B24"},{"key":"2023101001391016100_zwad080-B25","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00125-008-1246-y","article-title":"Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian diabetes, obesity, and lifestyle (AusDiab) study","volume":"52","author":"Barr","year":"2009","journal-title":"Diabetologia"},{"key":"2023101001391016100_zwad080-B26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/CIRCULATIONAHA.106.685628","article-title":"Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian diabetes, obesity, and lifestyle study (AusDiab)","volume":"116","author":"Barr","year":"2007","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B27","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European society of cardiology (ESC) and of the European association for the study of diabetes (EASD)","volume":"28","author":"Ryd\u00e9n","year":"2007","journal-title":"Eur Heart J"},{"key":"2023101001391016100_zwad080-B28","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B29","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B30","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American college of cardiology\/American heart association task force on practice guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP171764.APPGL","article-title":"AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE","volume":"23","author":"Jellinger","year":"2017","journal-title":"Endocr Pract"},{"key":"2023101001391016100_zwad080-B32","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"2023101001391016100_zwad080-B33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2015.01.039","article-title":"New insights into the pathophysiology of dyslipidemia in type 2 diabetes","volume":"239","author":"Taskinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"2023101001391016100_zwad080-B34","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"European Atherosclerosis society consensus panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"key":"2023101001391016100_zwad080-B35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the regulation of hepatic metabolism by insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"2023101001391016100_zwad080-B36","doi-asserted-by":"crossref","DOI":"10.1111\/j.1463-1326.2011.01423.x","article-title":"Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes","volume":"13","author":"Chaudhuri","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"2023101001391016100_zwad080-B37","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/dc13-1518","article-title":"Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release","volume":"37","author":"Garvey","year":"2014","journal-title":"Diabetes Care"},{"key":"2023101001391016100_zwad080-B38","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 Years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"2023101001391016100_zwad080-B39","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.amjcard.2019.05.035","article-title":"Control of cardiovascular risk factors among US adults with type 2 diabetes with and without cardiovascular disease","volume":"124","author":"Andary","year":"2019","journal-title":"Am J Cardiol"},{"key":"2023101001391016100_zwad080-B40","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023101001391016100_zwad080-B41","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"2023101001391016100_zwad080-B42","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1001\/jama.298.22.2654","article-title":"Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis","volume":"298","author":"Willi","year":"2007","journal-title":"JAMA"},{"key":"2023101001391016100_zwad080-B43","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.310.6979.555","article-title":"Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men","volume":"310","author":"Rimm","year":"1995","journal-title":"BMJ"},{"key":"2023101001391016100_zwad080-B44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cca.2018.08.001","article-title":"Classified status of smoking and quitting has different associations with dyslipidemia in residents in northeast China","volume":"486","author":"Shi","year":"2018","journal-title":"Clin Chim Acta"},{"key":"2023101001391016100_zwad080-B45","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/j.cca.2011.05.013","article-title":"Gender differences in the association between smoking and dyslipidemia: 2005 Korean national health and nutrition examination survey","volume":"412","author":"Lee","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2023101001391016100_zwad080-B46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.5551\/jat.34280","article-title":"Time-dependent changes of atherosclerotic LDL complexes after smoking cessation","volume":"23","author":"Komiyama","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"2023101001391016100_zwad080-B47","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.diabres.2012.06.007","article-title":"Trends in cigarette smoking among Spanish diabetic adults, 1987\u20132009","volume":"98","author":"Lopez-de-Andres","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"2023101001391016100_zwad080-B48","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1016\/S2468-2667(18)30026-4","article-title":"Smoking and smoking cessation in relation to risk of diabetes in Chinese men and women: a 9-year prospective study of 0\u00b75 million people","volume":"3","author":"Liu","year":"2018","journal-title":"Lancet Public Health"},{"key":"2023101001391016100_zwad080-B49","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(15)00340-2","article-title":"Contrasting male and female trends in tobacco-attributed mortality in China: evidence from successive nationwide prospective cohort studies","volume":"386","author":"Chen","year":"2015","journal-title":"Lancet"},{"key":"2023101001391016100_zwad080-B50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes Mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"2023101001391016100_zwad080-B51","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamacardio.2016.4700","article-title":"National trends in statin use and expenditures in the US adult population from 2002 to 2013: insights from the medical expenditure panel survey","volume":"2","author":"Salami","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2023101001391016100_zwad080-B52","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amjcard.2014.09.041","article-title":"Gender disparities in evidence-based statin therapy in patients with cardiovascular disease","volume":"115","author":"Virani","year":"2015","journal-title":"Am J Cardiol"},{"key":"2023101001391016100_zwad080-B53","doi-asserted-by":"crossref","first-page":"e005562","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2023101001391016100_zwad080-B54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/eurjpc\/zwaa144","article-title":"Gender gap in risk factor control of coronary patients far from closing: results from the European society of cardiology EUROASPIRE V registry","volume":"29","author":"Vynckier","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023101001391016100_zwad080-B55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/2047487315585293","article-title":"Time trends and gender differences in prevention guideline adherence and outcome after myocardial infarction: data from the SWEDEHEART registry","volume":"23","author":"Hambraeus","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2023101001391016100_zwad080-B56","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/heartjnl-2017-311429","article-title":"Sex differences in risk factor management of coronary heart disease across three regions","volume":"103","author":"Zhao","year":"2017","journal-title":"Heart"},{"key":"2023101001391016100_zwad080-B57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12933-015-0296-y","article-title":"Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational research programme of the European society of cardiology","volume":"14","author":"Gyberg","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"2023101001391016100_zwad080-B58","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: A European society of cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"2023101001391016100_zwad080-B59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/2047487314529353","article-title":"Does pharmacologic treatment in patients with established coronary artery disease and diabetes fulfill guideline recommended targets? A report from the EUROASPIRE III cross-sectional study","volume":"22","author":"Gyberg","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"2023101001391016100_zwad080-B60","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2337\/dc10-1314","article-title":"Implications of alternative definitions of prediabetes for prevalence in U. S. adults","volume":"34","author":"James","year":"2011","journal-title":"Diabetes Care"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwad080\/49724568\/zwad080.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/14\/1513\/51953742\/zwad080.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/14\/1513\/51953742\/zwad080.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:41:27Z","timestamp":1696902087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/30\/14\/1513\/7079736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":60,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,3,17]]},"published-print":{"date-parts":[[2023,10,10]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwad080","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,3,17]]}}}